Amicus Therapeutics' Series B Round

Amicus Therapeutics raised a round of funding on May 24, 2004.

Amicus (NASDQ:FOLD) is a biopharmaceutical company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases.…

Articles about Amicus Therapeutics' Series B Round: